Efficacy, safety, and tolerance of the non-ergoline dopamine agonist pramipexole in the treatment of advanced Parkinson's disease: a double blind, placebo controlled, randomised, multicentre study. (Q35450779)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Efficacy, safety, and tolerance of the non-ergoline dopamine agonist pramipexole in the treatment of advanced Parkinson's disease: a double blind, placebo controlled, randomised, multicentre study.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10201413%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

Efficacy, safety, and tolerance of the non-ergoline dopamine agonist pramipexole in the treatment of advanced Parkinson's disease: a double blind, placebo controlled, randomised, multicentre study (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10201413%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

0 references

multicenter clinical trial

0 references

Parkinson's disease

1 reference

based on heuristic

inferred from title

Michaela Pinter

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10201413%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

author name string

O Pogarell

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10201413%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

W H Oertel

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10201413%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

language of work or name

0 references

publication date

1 April 1999

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10201413%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

Journal of Neurology, Neurosurgery and Psychiatry

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10201413%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

66

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10201413%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10201413%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

436-441

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10201413%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

Steady-state pharmacokinetic properties of pramipexole in healthy volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736320

12 July 2018

In vivo comparisons of the effects of quinpirole and the putative presynaptic dopaminergic agonists B-HT 920 and SND 919 on striatal dopamine and acetylcholine release.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736320

12 July 2018

Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736320

12 July 2018

Erythromelalgia-like eruption in parkinsonian patients treated with bromocriptine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736320

12 July 2018

Parkinsonism: onset, progression, and mortality

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736320

12 July 2018

The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736320

12 July 2018

Double-blind comparison of pramipexole and bromocriptine treatment with placebo in advanced Parkinson's disease. International Pramipexole-Bromocriptine Study Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736320

26 September 2018

Retroperitoneal fibrosis and treatment of Parkinson's disease with high doses of bromocriptine

1 reference

https://pubmed.ncbi.nlm.nih.gov/10201413

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bromocriptine and pleuropulmonary disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/10201413

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dopamine receptor agonist potencies for inhibition of cell firing correlate with dopamine D3 receptor binding affinities

1 reference

https://pubmed.ncbi.nlm.nih.gov/10201413

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pramipexole in patients with early Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/10201413

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of pramipexole, a novel dopamine (DA) agonist, in advanced Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/10201413

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical evaluation of pramipexole in advanced Parkinson's disease: Results of a double-blind, placebo-controlled, parallel-group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/10201413

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of pramipexole, a novel dopamine agonist, as monotherapy in mild to moderate Parkinson's disease. The Pramipexole Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10201413

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/JNNP.66.4.436

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10201413%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10201413%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10201413%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35450779&oldid=1525733068"